CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercialization
By SquaredTown on January 28, 2026
Enabling Direct Therapeutic Access Beyond the Blood-Brain Barrier BALTIMORE, Jan. 28, 2026 /PRNewswire/ -- CraniUS Therapeutics LLC, a privately held neurotechnology company, today announced it has raised $20 million in Series B financing to accelerate development of NeuroPASS™, a fully...